Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Oncolytics Biotech Inc T.ONC

Alternate Symbol(s):  ONCY

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Comment by canadafanon Feb 07, 2023 10:04pm
246 Views
Post# 35273475

RE:Shareholders rights

RE:Shareholders rights

The BOD represents shareholders. Only after a preliminary agreement is negotiated & signed off by both bOD of for example ONC & Roche would that " deal " be presented to shareholders for final approval.
The executive or BOD can give their recommendations for accepting or not. ...to the shareholders.
The job of BOD is to evaluate any negotiations & give recommendations along the way etc.
As well as financial & legal consultants one representing each party, would give their opinion of fair value or not.
Brining shareholders into the mix prior to proper negotiations,legal & comercial considerations would be disastrous.
I have been part of 3 companies " taken over". By the time it gets to a shareholder rights vote, every single "I" has been dotted & "T" crossed.
Including a multi- page transcript of lead up negotiations. Who offered what & on what date & time.
There are 1000s of individual shareholders.
most of which have little understanding of running a biotech business, let alone how to buy one.
Some shareholders would be thrilled for $5ps.
some dissapinged with $15ps.
Any deal negotiated would be in the best interst ( both in details & $$$), of the ONC corporation as a whole.
keeping Pelareorep active, into a markets & as much $$$ as possibly can be paid for that opportunity.
one exception, a hostile takeover.
The aquiring company would bypass mangement & BOD , making a public offer with drop dead dates...direct to shareholders.
The danger of that. If the offer is too low. Mangement & BOD , would submit counter proposal publicly.
then you could have a vulture fund or second bidder ( white knight) come into the game.
The whole hostile takeover thing can fail.
Best opportunity, those in the business with hired outside consultants to assist with evaluations, come to a predetermined negotiation deal.
shaeholders , do then have right to accept or decline the proposal.
That offer would come voting instructions, dates etc etc.
So unless you have majority ownership & seat on the board, you must rely on those running the company to run the company.
They BTW have huge incentive to get best deal possible. With both shares & enough options to make a huge difference in their lives.
trust me, they want a deal as much as any sheholder does.
The more the better.
there will be third party evaluations included in any offer presentation. That is part of their due diligence & requirements to show non- bias in decisions.
like i said. I was shareholder of 3 companies bought out.
The package, included a timline of discussions, proposals & counter proposals.including rational of final agreement.
lawyers, accountants, detailed auditors etc. 
a buyout of a public traded company comes with a lot of reporting rules.
from the moment of first meeting to last, every discussion will be logged & documented.
So , no any " offer" does not need to be made public.
A negotiated deal, absolutely.


 

 

<< Previous
Bullboard Posts
Next >>